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Abstract
Background Following evidence published in the Pharmacists in Emergency Departments (PIED 2016) study Health Edu-
cation England funded novel advanced clinical practitioner training for pharmacists (ACP-p), to support service delivery.
Objective To explore experiences and clinical activity of trainee ACP-p, and opinions and recommendations of both trainees 
and clinical supervisors.
Setting Five Urgent/Emergency Care Departments in London UK.
Method Longitudinal mixed-methods study in three phases of registered UK pharmacists appointed as trainee ACP-p. Phase 
1 (May-July 2019) – early semi-structured interviews and focus group using an experiences, opinions and recommendations 
(EOR) framework, Phase 2 (January-December 2019) – prospective recording of trainee clinical activity, standardised using 
bespoke spreadsheet, Phase 3 (November-December 2019) – as Phase 1 but at conclusion of training.
Main outcome measure Experiences, clinical activity, opinions and recommendations of study participants.
Results Twelve (92 %) eligible trainee ACP-p and five supervisors were recruited. Identified themes were: trainee personal-
ity, educational components, length of programme, support/supervision, career transition, university and placement training 
alignment, recommendations. Success was dependent on effective support and supervision. Clinical supervisors should be 
allocated adequate supervision time. Trainees, their supervisors and emergency department staff should be given a clear 
brief. Study participants agreed that the programme could be successful. Trainee ACP-p reported that they could manage 
82 % of 713 pre-selected clinical presentations. Additional training needs include: ECGs, X-rays and CT scans.
Conclusions Pharmacists can successfully train as ACP-p in this setting over a two-year period. This career transition needs 
careful management and clear structures. Training ACP-p is a useful way of enhancing skills and supporting clinical services 
to large numbers of patients.
Keywords Advanced clinical practitioner · Emergency care · Emergency department · Pharmacist practitioner · United 
Kingdom
Impacts on practice
• Advanced clinical practitioner pharmacists (ACP-ps) are 
a potential clinical workforce and can be utilised by fur-
ther training to work in the multi-disciplinary emergency 
department (ED) or urgent care workforce.
• ACP-ps as a form of workforce retention should be 
explored as part of any strategy to transition this pilot 
into core business across NHS Service Providers.
• ACP-ps may be an option to fill the gaps in the clinical 
workforce in urgent and emergency care.
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Introduction
The Pharmacists in Emergency Departments (PIED) study, 
published in 2017, is one of the largest studies relating 
to pharmacists and clinical practice [1]. After consider-
ing 18,613 patient attendances in emergency departments 
(ED) across 49 English hospitals the authors concluded 
that pharmacists have the potential to manage 36 % of all 
presentations. Within this context manage included diag-
nosis, treatment, and admission or discharge to or from 
hospital. PIED data was instrumental in identifying the 
details of further training that pharmacists would need to 
fulfil an advanced patient clinical management role. Health 
Education England (HEE) has responsibility for training 
over 1.3  million NHS employees in the UK [2]. HEE 
funded the PIED studies and commissioned new train-
ing programmes to support pharmacists in achieving their 
aspirations as advanced clinical practitioners [3].
In recent years a framework for training Advanced 
Clinical Practitioners (ACP) has been established in the 
UK [4]. The associated training programme allows entry 
of registered healthcare professionals to become ACPs. 
Although this is predominately nurses, pharmacists and 
other healthcare professionals can also enter the pro-
gramme. Whilst pharmacists will bring a background in 
medicines optimization, all ACPs from any profession 
provide clinical management of patients and contribute 
to other pillars of ACP practice including: leadership, 
education and training, and research [4]. Pharmacists are 
eligible to train as ACPs, (denoted as ACP-p in this article) 
if they are registered and have suitable post-registration 
experience – usually two years or more. Other postgradu-
ate qualifications are not formally required. To become 
recognised as an ACP-p, pharmacists must complete an 
approved University programme (Level 7, to at least post-
graduate diploma) lasting at least one year, together with 
agreed clinical placements. Assessments relate to the 
four pillars of ACP: clinical practice, leadership, educa-
tion and training, and research and include independent 
prescribing.
Healthcare workforce challenges in urgent and emer-
gency care settings are recognised as a significant issue 
affecting NHS service delivery in the UK [5–7]. There is 
increased patient demand coupled with shortages in the 
number of doctors. European countries and elsewhere have 
dealt with the situation by restructuring the workforce and 
mobilising the clinical non-medical workforce [7–13].
From September 2016 to July 2020 Health Educa-
tion England (HEE) invested in 17 pharmacists in three 
cohorts to train as advanced clinical practitioner phar-
macists (ACP-p) within the urgent and emergency care 
setting. This included an 18-month full-time placement 
in one or more study site urgent/emergency care centres 
and enrolment on an agreed university-based ACP training 
programme.
The lack of a universally accepted definition of an 
advanced practice relating to pharmacists proves to be a 
challenge when drawing comparisons between countries. 
In Europe for example, literature identifying the role of 
advanced practice pharmacists is almost non-existent, mostly 
focusing on the role of the pharmacist in providing phar-
maceutical care in the traditional sense in the emergency 
department (ED) setting and beyond [14].
Aim of the study
To explore the experiences, opinions and recommendations 
of trainee ACP-p, and their clinical supervisors, who were 
undertaking advanced clinical practitioner training at five 
London teaching hospitals, and identify recommendations 
for further consideration of training, funding and support.
Ethics approval
This evaluation study was approved by the Health Research 
Authority (HRA) on 4th February 2019 – IRAS 249,416, 
commissioned by HEE and sponsored by Aston University.
Methods
Longitudinal, mixed-methods, multisite, study of trainee 
ACP-p and their clinical supervisors.
This study was undertaken in three phases. Phase 1 
included early semi-structured one-to-one interviews (SSI) 
with trainee ACP-p and clinical supervisors in the current 
cohorts. Participant information sheets were provided and 
hard-copy signed consent forms obtained prior to data cap-
ture. Findings from the SSIs were used to inform a later 
focus group consisting of all participating trainee ACP-p. 
Experiences (what had actually occurred), opinions (what 
the participants think or feel), and recommendations (EOR 
methodology) formed the basis of the interview and focus 
group framework, and were followed sequentially accord-
ing to the a priori agreed design. The study was designed 
and conducted in accord with COREQ principles [15]. 
Since it was known that there was some variability in the 
training experienced by the individual participants, SSIs 
were conducted with all to identify relevant individual 
details. Focus groups allowed open discussion amongst the 
participants and led to consensus determination of issues 
and recommendations. Participants were judged to be eli-
gible if they were within six months of the start of the 
programme (n = 13, current cohorts). Interviews and focus 
groups were conducted by DT who was experienced in 
these techniques and setting, but was not previously known 
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to the participants. Both SSIs and focus group were audio 
recorded, transcribed and either thematically analysed [16] 
using a bespoke coding framework or subjected to nar-
rative analysis by two researchers (SG, and KCH), who 
produced and confirmed anonymised summary findings, 
reviewed by CH and DT. Early data was primarily subject 
to narrative analysis to identify experiences and opinions 
(how, why), latter data was subject to thematic analysis to 
support identification of recommendations (what).
Phase 2 provided the opportunity for participants to 
briefly record their own patient consultations using the 
method described by Hughes et al. [1]. Data recorded 
was: date, location, patient gender, age, presenting com-
plaint, clinical grouping, clinical skills required to manage 
patient, trained ability to manage patient (yes/no), further 
clinical skills needed if any, are these skills included in 
your training programme and comments. In this manner 
patient presentations, skills required to manage the patient 
and any personal skill gaps were identified. Records were 
completed using a bespoke online form designed in MS 
Excel 2013. Training was provided to the participants on 
how to complete these records. The study team monitored 
the records and had opportunity to provide further instruc-
tion on how the form was to be used if needed.
Phase 3 mirrored the methods used in Phase 1 but was 
conducted at the end of training programme, and focused 
on later stages of the programme and final recommenda-
tions identified in analysis of focus group and semi-struc-
tured interviews.
Data was stored on AES-256 protected electronic files 
approved for the purpose by Aston University.
Results
12 trainee ACP-p participated, with one trainee ACP-p 
declining.
Prior to joining the programme the trainees, all regis-
tered and experienced pharmacists, came from a variety 
of backgrounds, including:
• Nine hospital pharmacists.
• One interface pharmacist (between primary and sec-
ondary care).
• One pharmacist from primary/community care.
• One pharmacist from primary/secondary care.
Post-registration experience ranged from 3 to 8 years.
Four medical doctors and one advanced nurse practi-
tioner participated as clinical supervisors across the five 
study sites. Each supervised more than one trainee ACP-p.
Experiences and opinions of trainee ACP‑p
Trainee resilience
The majority of the ACP-p trainees said that they needed to 
be mentally strong and resilient to undertake the programme 
and to complete what is a ‘drastic’ change in their profes-
sional working lives. They expressed the view that it’s a 
difficult transition, and future trainees need to consider this 
carefully and be prepared for the challenges ahead.
I am the type of person to get on with things, in my 
opinion this helped the challenging transition period, 
but I appreciate that not everyone is like that you know 
and so if you’re not like that it would’ve been a strug-
gle. P5, Hospital Pharmacist.
Programme delivery and alignment
The ACP-p trainees felt they were disadvantaged by train-
ing site contracts lasting 18-months when the University 
programme lasted two years. They recommend that these 
periods of study should be aligned.
The job was advertised for 18-months whilst the post-
graduate ACP programme is for 2 years. There seems 
to be a disconnect between Trust competency require-
ment and university requirements. These should be 
aligned. P4, Hospital pharmacist.
Educational programme
The ACP-p trainees found the initial induction organised by 
Health Education England (HEE) to be useful and where 
hospitals/Trusts organised an additional induction to sup-
plement the first induction, it helped them transition into 
the role.
We had a 2-week introduction kind of timetable I 
believe from Health Education England when we 
started, with all the other ACP – p trainees from 
the different Trusts. Our ACP lead at the Trust also 
designed an induction timetable for us in the first 
month … If this wasn’t in place, I think it would have 
been very difficult to make that transition. P9, Hospital 
pharmacist.
The ACP-p trainees commented that achieving compe-
tence from a standing start in 18-months is a significant chal-
lenge for many, and a longer training period may be more 
realistic.
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I think HEE needs to know that it`s not an 18-month 
programme it’s a 3-year programme. P4, Hospital 
Pharmacist.
 Trainees benefited from the ACP course at the university 
especially in the early stages of training when they lacked 
clinical assessment skills.
Our first module was physical assessment and I think it 
was actually quite a good way of introduction into the 
programme. P10, Primary and Secondary Care Inter-
face pharmacist.
 It was noted that the trainees found the Trust-based train-
ing for junior doctors useful in terms of emergency care 
teaching.
The FY2 teaching is delivered by the A&E consultants 
and every week a different topic is discussed. It is a 
very well structured and focused sort of training. P9, 
Hospital Pharmacist.
Support
Some training sites had little previous exposure to pharma-
cists within their Emergency Departments, and where this 
is the case the role of pharmacists may be poorly understood 
and sometimes challenged. Sites which were well prepared 
for the introduction of pharmacist trainees generally pro-
vided a more comfortable learning experience for the phar-
macists and helped with integration into the team.
Some sites were described as welcoming and supportive.
I think our set up is good in that before we arrived 
people knew who we were. I think you really need all 
doctors in the department and the team to know who 
you are because it helps you integrate. P11, Hospital 
Pharmacist.
Some sites were described as ‘hostile’.
Lack of acceptance and hostility within the ED envi-
ronment made me feel unsupported and unwelcome. 
P12, Primary Care and Hospital Pharmacist.
Supervision
Supervision varied between the sites. Trainees benefiting 
from effective and accessible clinical supervision reported 
a good experience.
My clinical practice is supervised on an ad hoc basis 
by a consultant, no formal supervisor appointment to 
the position for about 12 months. As a result, I am 
planning to move on to a role where I will be able to 
develop my skills and be supervised by a nominated 
supervisor. P3, Hospital Pharmacist.
Excellent training base as holistic and well-rounded 
training with varied practitioners available. Several 
practitioners have also undertaken the ACP course and 
understand the learning needs from academic/univer-
sity and professional/practice-based perspective. This 
resulted in a positive experience during my training 
period. P1, Hospital Pharmacist.
Experiences and opinions of the clinical supervisors
Trainee response
The clinical supervisors’ findings mirrored the pharmacists’ 
opinions in terms of trainee response.
I think some of them have really picked things up very 
quickly depending on personality types and I think oth-
ers have not picked it up as quickly and I would say 
that it’s similar to what we have seen in nurses and 
doctors. P8, Consultant in Emergency Department.
A challenging experience
Clinical supervisors confirmed this was a challenging pro-
gramme and a first of its kind.
The programme is really exploring uncharted territory 
and is more embryonic than originally described and 
expected. Clinical pharmacists have very limited expe-
rience working in Urgent Care settings. P15, Consult-
ant in Emergency Department.
 In addition, differences in pay banding and salary intro-
duced tensions among non-medical colleagues.
Students (ACP-p trainees) are training and paid at 
8a – this exceeds expectations of other groups (e.g. 
nurses) with consequential problems. P15, Consultant 
in Emergency Department.
Programme delivery and alignment
The mismatch between contract of employment lasting 
18-months and university academic course running over 2 
years proved to be problematic.
I could not understand why it was 18 months, as far 
as I am concerned it is 2 years. P17, Advanced Nurse 
Practitioner.
Educational element
It was identified that ACP-p trainees may need a longer 
period to consolidate their knowledge in the emergency 
department setting.
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Pharmacists need a longer period to consolidate their 
knowledge than our nurse ACPs who have spent longer 
seeing patients in the emergency department. P8, Con-
sultant in Emergency Medicine.
The background training required includes modules such 
as anatomy.
The ACP pharmacist trainees’ actual clinical back-
ground was inadequate e.g. anatomy … P15, Consult-
ant in Emergency Medicine.
In the UK pharmacists can undertake further post-regis-
tration training to become fully independent prescribers. It 
was identified that completion of prescribing training prior 
to the study may be useful.
In retrospect, not having prescribing first made it too 
much to do in 18 months. P14, Consultant in Emer-
gency Medicine.
The knowledge required at the start of the programme is 
best acquired in another setting instead of in the emergency 
department.
I think it would have been better if they had some of 
the academic course before coming to us. P18, Urgent 
and Emergency Care Consultant / GP.
Support
The clinical supervisors found their own initial induction to 
be of limited benefit.
HEE provided an initial short training–2 weeks–cov-
ering some basics, which was useful but of limited 
benefit. P15, Consultant in Emergency Department.
The requirement to develop ACP-p in merely 2-years was 
a challenge.
When they`ve come from a very different background 
to support effectively, shoehorn all that training, all the 
theoretical knowledge that they need plus the practi-
cal knowledge into just two years, I think it is quite 
unrealistic expectation. P8, Consultant in Emergency 
Medicine.
The extent of support required by the trainees should not 
be underestimated.
You need to be aware that these trainees will need a 
lot more support in the early stages–which to be fair 
would be pretty obvious. I certainly didn’t feel that 
it was any more onerous for the senior clinical team 
to support them as opposed to other SHOs. Because 
they were very enthusiastic/seeking out training oppor-
tunities, helped them in that regard. P16, Emergency 
Medicine Consultant.
Supervision and governance
The supervision and competence element created unrest 
amongst the clinical supervisors.
The clinical supervisors are being asked to sign the 
trainees off as independent at the end of the first year, 
by University, when it was never the intention that they 
would be independent after only one year. P15, Con-
sultant in Emergency Medicine.
Lack of protected supervision time and extent of supervi-
sion required by ACP-p trainees was unsatisfactory to clini-
cal supervisors.
These ACP trainees really need a lot of support and 
a lot of supervision by a consultant and we raised the 
fact that we don’t have that capacity. P8, Consultant in 
Emergency Medicine.
Governance was initiated by the Trust with minimal or 
lack of input from HEE or the university.
Governance of the programme locally has been pro-
vided by the ACP Governance group–chaired by the 
Medical Director–who meet each month to consider 
progress, approach and actions. This is a bespoke 
group for this training programme. P15, Consultant in 
Emergency Medicine.
Project future and recommendations
Despite its shortcomings, this project could be successful 
with support from all stakeholders involved, and initial train-
ing to support ACP-p transition in their new roles.
The programme can work with commitment from all 
concerned (Trust, senior management, staff), clarity 
from the organisations over the programme arrange-
ments, and significant effort from the pharmacists 
themselves to engage as clinical students in an unfa-
miliar environment. P15, Consultant in Emergency 
Department.
The brief from HEE should be more structured and Trusts 
need to keep an open mind about the pilot.
If HEE is looking to promote this programme, as there 
is value, HEE needs to be more specific of what types 
of roles they want to fill and expectations of what 
period of time, these practitioners can be independent 
mid grades … P16, Emergency Medicine Consultant.
There is definitely a role for ACP-p.
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I would welcome the next cohort without doubt. When 
nurses started as ACP, it wasn’t accepted very well. 
The ACP-p trainees need to see why they want to do 
it, what their expectation is, have an understanding of 
what they are going to be doing so it gives them an 
idea to see if they want to take on the challenge and 
culture shock. P17, Advanced Nurse Practitioner.
Clinical activity data
Nine trainee ACP-p recorded details of 713 patients that 
they saw during the study in the period January to December 
2019 from four study sites.
Table 1 below shows the number of patients they saw in 
each clinical grouping as defined by Hughes et al. [1], and 
the number that they considered they could independently 
manage within their own skill set at the time. Patients were 
selected according to the trainees’ skills and training needs 
at the time of presentation. Trainees were supervised as part 
of the multidisciplinary team. Competence to manage was 
not formally assessed by another trained practitioner at an 
individual patient level.
Table 2 shows the numbers and proportions of patients 
recorded by trainee ACP-p that they considered they were 
competent to manage by site.
Trainees were asked to identify their own specific train-
ing needs to manage patients they saw, at the time of the 
consultation.
Training needs were recorded for 179 (25 %) patients. 
Of these, the trainees identified two or more training needs 
for 47 individual patients.
Table 3 shows the category, sub-category and frequency 
of training needs recorded by the ACP-p trainees.
Twenty recommendations were identified and are sum-
marised in Table 4 below.
Table 1  Numbers of patients recorded in clinical groups seen by 
trainee ACP-p and numbers that they considered they were competent 
to independently manage–all study sites
Clinical Grouping Independently 
manage = Yes
Total %Yes
Medical-general 154 174 89 %
Respiratory 85 106 80 %
Cardiology 55 74 74 %
Gastrology 59 66 89 %
Other 48 58 83 %
Neurology 44 55 80 %
Urology 27 33 82 %
Orthopaedics 20 28 71 %
Surgical-general 21 26 81 %
Ear-Nose-Throat 20 24 83 %
Trauma 20 24 83 %
Obstetrics and Gynaecology 11 14 79 %
Pain 12 14 86 %
Renal 7 12 58 %
Liver 3 3 100 %
Paediatrics 1 2 50 %
Totals 587 713 82 %
Table 2  Numbers and 
proportions of patients seen by 
trainee ACP-p at four study sites
Site Manage = Yes Total
1 207 (72 %) 287
2 77 (76 %) 101
3 236 (92 %) 256
4 67 (97 %) 69
Table 3  Category, sub-category and frequency of training needs 





Computed tomography All 33
Head n=15






Arterial blood gases 5
Fundoscopy 5
Rectal examination 5




















Experiences and opinions of participants were not always 
aligned. It is evident that Trusts providing effective support 
and supervision created a more welcoming environment for 
the pharmacists.
There is a paucity of evidence identifying exact number 
of training hours that translate into core competencies [17]. 
It is recommended that these be identified and communi-
cated consistently to all pilot sites for similar projects in the 
future. This would enable trainees to be aware of what is 
expected of them, types of patients they will see and which 
areas of urgent or emergency care they will work in.
This study highlights the importance of appreciating that 
immediate reduction in workload may not be seen. Signifi-
cant support is required in the interim period [18]. Clinical 
supervisors noted the training burden on Emergency Depart-
ment staff, and any extra training arrangements for ACP-p 
trainees need to be carefully considered at each site.
Clarity of new roles as they are introduced is essential 
and this reflects findings in many workforce development 
programmes [19]. Evidently, this promotes ease of integra-
tion for the trainees into a fast paced and rapidly changing 
environment for new members of the team [10]. Trainees 
reported negative impact when staff in the ED were not 
aware of why they were there and the extent of their new 
role. This finding matches evidence documented in literature 
on integration of pharmacists into the urgent care setting 
[20].
Liberati identified that integration is impeded by the need 
to defend ‘…discipline specific professional identities, spe-
cialised knowledge and pre-existent practices’ [21]. This is 
supported by literature addressing resistance to collaboration 
if one’s role is perceived as being threatened [22]. At some 
training sites it was noted that there is a tension between 
existing non-medical staff and the ACP-p trainees, perhaps 
prompted by salary differentials and roles.
The study participants noted the benefit of placing stu-
dents at training sites who have a genuine interest in the 
future employment of ACP-p, as opposed to sites sim-
ply willing to provide the training without any future 
expectations.
Trainees
The journey - transitioning into this autonomous role - was 
in parts challenging for the trainees.
Table 4  Recommendations in relation to ACP-p training by category
1 Sites Provide effective support and supervision
2 Sites To be made aware of the additional training burden on staff
3 Sites Ensure ED staff are aware of programme and trainee needs and role.
4 Sites Beneficial if the ED department has had prior exposure to clinical pharmacists
5 Sites Beneficial if the ED department has commitment to long term employment of ACP-p
6 Trainees Be prepared for the challenges of transitioning to a new role
7 Trainees Be prepared that this is a training role, requiring significant personal study time in addition to placement work 
time.
8 Supervision/ supervisors Provide effective, protected and accessible clinical supervision
9 Supervision / supervisors Supervisors to receive adequate induction and attend University training day.
10 Supervision/ supervisors Support of ACP-p trainees should not be underestimated, who may require more supervisor time that trainees 
from other professions.
11 Supervision/ supervisors Trainees may need more than one supervisor.
12 Training programme Align University and placement periods
13 Training programme Provide organisational and local inductions
14 Training programme Minimum of two years
15 Training programme Placement training with junior doctors
16 Training programme Provide pre-programme training (e.g. anatomy etc. in a bridging module) and experience (in another clinical 
environment)
17 Training programme Where possible trainees to complete independent prescribing prior to ACP-p training
18 Training programme Include early training in ECGs, Chest x-rays and CT scans
19 Health education England Provide a clear description of the programme to all interested parties, including written Job Descriptions and 
support arrangements
20 Health education England Recruit sites, supervisors and trainees carefully. Sites require a supportive team, supervisors need adequate 
time, and trainees must be willing to study outside of work time.
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Trainees need to be resilient and proactive [23] not so 
much in dealing with the work of the Emergency Depart-
ment, but rather about the transition in roles that they are 
likely to experience. Shop-floor clinical teaching is not the 
norm for pharmacists compared to medical doctors [24]. 
Currently pharmacists lack clinical assessment and diagno-
sis training at undergraduate level compared to their medical 
counterparts [24, 25].
It was identified that ACP-p trainees should make full use 
of the wide range of teaching materials available to them and 
put in considerable time both within the learning environ-
ment and away from it to enhance their learning. Literature 
highlights the disadvantaged positions that pharmacists are 
in compared to nurses when embarking on advanced roles 
[26]. The lack of patient contact, anatomical knowledge 
and diagnostic skills were identified as potential barriers to 
encroachment of traditional roles of nurses and doctors [27, 
28].
Records of clinical activity confirm the ACP-p trainees 
saw a wide range of patients, with 82 % considered by the 
trainees themselves to be within their competence to man-
age. Unlike the PIED study [1] where pharmacists were 
asked to assess a representative sample of all ED patient 
presentations, in this present study ACP-p trainees recorded 
activity with patients they were directed to, or chose to man-
age. The ability to manage these targeted patients was self-
assessed by the trainees themselves. It is therefore not sur-
prising that their ability to manage large numbers of patients 
is confirmed in this study.
Supervisors/supervision
Good and effective supervision was found to be helpful in 
alleviating the anxiety associated with the transition to a new 
role [29]. Given the novelty of this project, supervisors were 
mostly physicians. Barton identifies the challenges with one 
professional body mentoring another as highlighted by some 
ACP-p trainees [30]. A description of the trainees’ educa-
tional backgrounds to inform prospective training sites of 
their clinical training would be beneficial.
Clinical supervisors should attend the University pro-
gramme training day and be given sufficient information to 
support realistic expectations of ACP-p trainees. More than 
one clinical supervisor may be necessary in order to cover 
absences especially where there are a group of trainees at 
the site. Literature explains that the supervision arrange-
ment whether formal or informal influences the success of 
the mentorship [31].
Training programme
ACP-p trainees welcome a structured and agreed train-
ing pathway with suitable inductions. Aligning academic 
courses with training placements is essential. It is recom-
mended that a bridging module be introduced prior to the 
trainees embarking on the ACP course and that the duration 
of the ACP and bridging course be longer than 2 years. It 
may be advantageous for independent prescribing training to 
be completed before or early in the training programme. In 
the near future the General Pharmaceutical Council expects 
pharmacists to be independent prescribers at the time of pro-
fessional registration.
Some exposure to the environment and associated 
skills required prior to undertaking a training role will be 
advantageous.
Further training relating to ECG, X-ray and CT scans are 
identified as priorities.
Health education England (funding body)
Both ACP-p trainees and their clinical supervisors observed 
that HEE provided very limited guidance concerning the 
training programme. HEE should provide a clear description 
of the programme to all stakeholders, highlighting required 
actions by NHS training sites.
Study training sites should be chosen carefully according 
to the support they can offer trainees. It may be beneficial 
to choose sites that have some experience of working with 
pharmacists that are able to provide a structured training 
programme integrated with other professional trainees.
It is the recommendation of this study that educational 
and clinical supervisors should be carefully chosen perhaps 
following interviews, provided with a written job description 
and supported from the Trust and HEE alike. Supervisors 
should be advised of the strengths and weaknesses of train-
ees from a pharmacy background, and given sufficient time 
to provide appropriate support.
The limitations of this study include metrics were not 
gathered to estimate development of skills or contribution to 
workload. In addition, there were limited published literature 
on ACP-p [32]. Most advanced practice literature involves 
nurses. There exist fundamental differences in the training, 
career progression and governance structure for each of the 
professions respectively [23]. Another limitation was that 
the participants were at different stages on the programme at 
any one time. Feedback may have been skewed to how they 
felt at the point of data collection. All participants worked in 
slightly different environments and scope of practice varied 
according to Trust requirements and governance structures. 
Trainees self-assessed their ability to manage patients, which 
was not independently verified by a trained practitioner.
Overall, participants consider the training programme 
evaluated in this study to be adequate to support pharmacists 
to become ACP-p, but can be much improved. All stake-
holders should consider and agree actions in response to the 
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recommendations, to enable all concerned to be prepared for 
this challenging transition in career.
Further work is required to determine if the identified 
recommendations lead to practical and deliverable training 
for pharmacists transitioning to ACP-p.
Conclusions
Recommendations have been identified that will improve 
ACP-p future training programmes. The transition from 
traditional pharmacy roles to those of an ACP-p is chal-
lenging, but achievable. Programme providers should ensure 
that sites are suitably supportive, supervisors are aware of 
the challenges and given sufficient time to fulfil their train-
ing role, and trainees need to commit to intensive training 
beyond what can be achieved in the normal working day. 
In-practice and university training need to be aligned.
Developing ACP-ps has a future and should be considered 
when developing workforce initiatives. Training ACP-p is 
a useful way of enhancing skills, providing a new career 
pathway and encouraging staff retention as outlined in the 
NHS Interim Plan [33].
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